The Silent Risk: Women, Heart Disease, and the Research Gaps That Cost Lives
Heart disease is the leading cause of death in women. Yet many women do not see it as their biggest threat.
We talk about breast cancer often, and that matters. But cardiovascular disease takes more women’s lives each year than all cancers combined. The danger is not just the disease itself. It is how often women are overlooked, misunderstood, or treated too late.
This is not a failure of women paying attention. It is a failure of research, education, and clinical systems built around male bodies.
When women are underrepresented, their symptoms, risks, and responses to treatment are less likely to be fully understood.
Why Women’s Heart Disease Is Still Missed
For decades, cardiovascular research focused largely on men. As a result, much of what we know about diagnosis, treatment, and medication dosing is based on male physiology.
Between the mid-1990s and 2015, women made up less than one third of participants in many major heart disease trials. In some surgical studies, female participation dropped closer to one fifth. Even in large government funded trials, women rarely exceeded forty percent of participants.
This matters because research shapes guidelines. Guidelines shape care. And care shapes outcomes.
When women are underrepresented, their symptoms, risks, and responses to treatment are less likely to be fully understood.
Has Representation Improved?
Some progress has been made, but it has been slow.
From 2010 through 2019, women made up roughly thirty eight to thirty nine percent of participants in cardiovascular trials. Large reviews published as recently as 2024 show only small yearly increases in female enrollment.
In practical terms, that means women are still not represented in numbers that match their disease burden. This gap is even wider in conditions like coronary artery disease and heart failure, where women face high risk but remain less studied.
Statins and the Missing Female Data
Statins are among the most commonly prescribed medications for heart disease prevention. Yet women were a minority in the trials that led to their widespread use.
Across major statin studies involving more than one hundred thousand participants, fewer than thirty percent were women. In some prevention trials, women made up closer to ten percent.
While pooled data suggest statins reduce cardiovascular events in both men and women, important questions remain. In women without known heart disease, the benefit is less clear. Side effects and medication tolerance may also differ, but these outcomes are rarely reported separately for women.
What this means in practice is that women are often prescribed medications based on incomplete sex specific data. That should concern all of us.
Menopause Is a Major Turning Point for the Heart
One of the most striking gaps in heart disease care for women involves menopause.
As estrogen levels decline, cardiovascular risk rises. LDL cholesterol increases. Blood vessels become less flexible. Visceral fat increases. Insulin sensitivity declines. These changes are not subtle.
Yet menopause is still not consistently included as a formal risk factor in many heart disease calculators or guidelines. A woman in her early fifties may show multiple warning signs, but her calculated risk may still appear low because the model does not reflect her biology.
This leads to delayed prevention. And delay costs lives.
Symptoms in Women Often Look Different
Another reason women are misdiagnosed is that heart disease does not always present the same way.
How Women Commonly Present (Atypical—but Common in Women)
Women are less likely to have classic chest pain and more likely to experience diffuse, non-specific symptoms, including:
Chest Discomfort (Not Always “Pain”)
Tightness
Burning
Pressure
Fullness (May come and go)
Shortness of Breath
With or without chest symptoms
Often misattributed to anxiety or deconditioning
Unusual Fatigue
Sudden, overwhelming exhaustion
Feeling “flu-like” or drained
Can occur days to weeks before the event
Gastrointestinal Symptoms
Nausea
Vomiting
Indigestion
Upper abdominal pain
Pain Outside the Chest
Jaw
Neck
Shoulder
Upper back
Between the shoulder blades
Autonomic / Neurologic Symptoms
Lightheadedness or dizziness
Cold sweats
Anxiety or a sense of impending doom
When these symptoms are dismissed or attributed to stress, anxiety, or aging, opportunities for early intervention are lost.
Risk Factors
The risk factors associated with increased heart disease risk in women:
Frequent, early, or severe hot flashes are associated with increased cardiovascular risk.
Infertility
Endometriosis
Fibroids
Preterm Birth
Early or premature Menopause for any reason (natural or surgical)
Three Conversations Every Woman Should Have
If you are in midlife or beyond, these questions matter.
First, ask about your personal risk. Not averages. Your blood pressure, cholesterol, blood sugar, family history, weight changes, and menopause status all count.
Second, ask what heart symptoms could look like for you. Know the warning signs that apply to women, not just men.
Third, ask how prevention strategies apply to women specifically. That includes medications, lifestyle changes, and monitoring for side effects.
These conversations shift care from generic to personal.
What Needs to Change
Closing the gender gap in heart disease care requires action.
Clinical trials must enroll women in numbers that reflect reality. Journals and regulators must require sex specific reporting. Guidelines must account for menopause as a meaningful risk factor. And clinicians must be trained to recognize how heart disease presents in women.
Most of all, women need clear, honest information about their risk. Knowledge leads to earlier care. Earlier care saves lives.
Heart disease is not a man’s problem. It is a woman’s issue too. And women deserve care built on evidence that includes them.
Defy Menopause - Own the Change
Many women tell me: "One day I feel amazing. The next, I can barely get out of bed. Is this normal?"
Yes, it is. And no, you don’t have to suffer through it alone.
Hormonal fluctuations during perimenopause can make you feel like you’ve lost control of your body. But knowledge is powerful. And there are clear, science-backed ways to support your hormones, ease symptoms, and reclaim your energy.
That’s exactly why I created Defy Menopause: Own the Change — a 30-day program designed to give you the tools, knowledge, and support you need to move through these changes with clarity and confidence.
Inside, you’ll find:
Weekly access to Dr. Tracy Verrico at live, group sessions
Clear action steps for managing symptoms naturally
Because you deserve more than just "putting up with it."
You deserve to thrive.
Let’s Connect
Schedule an Appointment | LinkedIn | YouTube | Instagram | Bona Dea Gynecology
References
Nguyen JT et al. Sex differences in randomized controlled trials in cardiology. Journal of the American College of Cardiology. 2018.
Gaudino M et al. Representation of women in cardiac surgery trials. European Journal of Cardio-Thoracic Surgery. 2021.
Harris DJ, Douglas PS. Enrollment of women in cardiovascular trials. Journal of the American College of Cardiology. 2000.
Stramba-Badiale M et al. Gender issues in cardiovascular research. European Heart Journal. 2010.
Jin X et al. Participation of women in cardiovascular clinical trials. Circulation. 2020.
Wu J et al. Sex representation in NIH funded cardiovascular trials. Journal of Women’s Health. 2023.
Chi G et al. Global trends in sex representation in cardiovascular trials. The Lancet. 2024.
Kostis WJ et al. Statin therapy and cardiovascular risk in women. Journal of the American College of Cardiology. 2012.
Petretta M et al. Statins for primary prevention in women. American Journal of Cardiology. 2010.
Lewey J et al. Sex differences in statin adherence. Circulation. 2013.
Goldstein KM et al. Gender differences in statin use and adverse effects. Journal of General Internal Medicine. 2016.
Medical Disclaimer: The information provided in this newsletter is for general educational and informational purposes only and is not intended as, nor should it be considered, medical advice. This content does not establish a physician-patient relationship and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read in this newsletter. If you think you may have a medical emergency, call your doctor or emergency services immediately.
